
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
Karoline Kielbassa, Serena Vegna, Christel Ramirez, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 72
Karoline Kielbassa, Serena Vegna, Christel Ramirez, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 72
Showing 26-50 of 72 citing articles:
Myeloid cell path to malignancy: insights into liver cancer
Christel Ramirez, Leila Akkari
Trends in cancer (2025)
Open Access
Christel Ramirez, Leila Akkari
Trends in cancer (2025)
Open Access
Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
Johanna Erbani, Menno Boon, Leila Akkari
Seminars in Cancer Biology (2022) Vol. 86, pp. 41-56
Closed Access | Times Cited: 19
Johanna Erbani, Menno Boon, Leila Akkari
Seminars in Cancer Biology (2022) Vol. 86, pp. 41-56
Closed Access | Times Cited: 19
CircASPH Enhances Exosomal STING to Facilitate M2 Macrophage Polarization in Colorectal Cancer
Yuting Zhang, Jiakun Guo, Liyin Zhang, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 12, pp. 1941-1956
Closed Access | Times Cited: 11
Yuting Zhang, Jiakun Guo, Liyin Zhang, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 12, pp. 1941-1956
Closed Access | Times Cited: 11
Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies
Yijia Zhang, Xiaofei Ding, Xue Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Yijia Zhang, Xiaofei Ding, Xue Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models
Rachel Ringquist, Delta Ghoshal, Ritika Jain, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114003-114003
Open Access | Times Cited: 25
Rachel Ringquist, Delta Ghoshal, Ritika Jain, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114003-114003
Open Access | Times Cited: 25
The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy
Ali Baradaran, Zahra Asadzadeh, Nima Hemmat, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112588-112588
Open Access | Times Cited: 23
Ali Baradaran, Zahra Asadzadeh, Nima Hemmat, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112588-112588
Open Access | Times Cited: 23
Amphiphilic galactomannan nanoparticles trigger the alternative activation of murine macrophages
Ella Peled, Alejandro Sosnik
Journal of Controlled Release (2021) Vol. 339, pp. 473-483
Closed Access | Times Cited: 20
Ella Peled, Alejandro Sosnik
Journal of Controlled Release (2021) Vol. 339, pp. 473-483
Closed Access | Times Cited: 20
Good CARMA : Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages
Christopher M. Snyder, Saar Gill
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 236-249
Closed Access | Times Cited: 7
Christopher M. Snyder, Saar Gill
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 236-249
Closed Access | Times Cited: 7
Alveolar macrophages in lung cancer: opportunities and challenges
Cheng-Yen Chang, Dominique Armstrong, David B. Corry, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Cheng-Yen Chang, Dominique Armstrong, David B. Corry, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists
J Filderman, Jennifer L. Taylor, Jianmin Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
J Filderman, Jennifer L. Taylor, Jianmin Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
A detailed insight into macrophages' role in shaping lung carcinogenesis
Tamanna Aktar, Snehashish Modak, Debabrata Majumder, et al.
Life Sciences (2024) Vol. 352, pp. 122896-122896
Closed Access | Times Cited: 2
Tamanna Aktar, Snehashish Modak, Debabrata Majumder, et al.
Life Sciences (2024) Vol. 352, pp. 122896-122896
Closed Access | Times Cited: 2
Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma
Han Liu, Zongwei Lv, Gong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Han Liu, Zongwei Lv, Gong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
FSTL1 Suppresses Triple-Negative Breast Cancer Lung Metastasis by Inhibiting M2-like Tumor-Associated Macrophage Recruitment toward the Lungs
Ying Yang, Tao Lu, Xiaowei Jia, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1724-1724
Open Access | Times Cited: 6
Ying Yang, Tao Lu, Xiaowei Jia, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1724-1724
Open Access | Times Cited: 6
High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis
Rohit Gaurav, Ted R. Mikuls, Geoffrey M. Thiele, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0240707-e0240707
Open Access | Times Cited: 15
Rohit Gaurav, Ted R. Mikuls, Geoffrey M. Thiele, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0240707-e0240707
Open Access | Times Cited: 15
The Adhesome Network: Key Components Shaping the Tumour Stroma
Pinelopi Nikolopoulou, Maria A. Koufaki, Vassiliki Kostourou
Cancers (2021) Vol. 13, Iss. 3, pp. 525-525
Open Access | Times Cited: 15
Pinelopi Nikolopoulou, Maria A. Koufaki, Vassiliki Kostourou
Cancers (2021) Vol. 13, Iss. 3, pp. 525-525
Open Access | Times Cited: 15
<p>Cancer-Derived Transforming Growth Factor-β Modulates Tumor-Associated Macrophages in Ampullary Cancer</p>
Li-Chin Cheng, Ying‐Jui Chao, Chih‐Yang Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7503-7516
Open Access | Times Cited: 15
Li-Chin Cheng, Ying‐Jui Chao, Chih‐Yang Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7503-7516
Open Access | Times Cited: 15
Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
Chiara Cilibrasi, Panagiotis Papanastasopoulos, Mark Samuels, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 12015-12015
Open Access | Times Cited: 13
Chiara Cilibrasi, Panagiotis Papanastasopoulos, Mark Samuels, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 12015-12015
Open Access | Times Cited: 13
Tumor-associated macrophages in lung carcinoma: From mechanism to therapy
Xueying Wang, Yining Wu, Jiahui Gu, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153747-153747
Closed Access | Times Cited: 13
Xueying Wang, Yining Wu, Jiahui Gu, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153747-153747
Closed Access | Times Cited: 13
New insights into the interaction of the immune system with non-small cell lung carcinomas
Paul Hofman
Translational Lung Cancer Research (2020) Vol. 9, Iss. 5, pp. 2199-2213
Open Access | Times Cited: 13
Paul Hofman
Translational Lung Cancer Research (2020) Vol. 9, Iss. 5, pp. 2199-2213
Open Access | Times Cited: 13
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles
Yitian Xu, Licheng Zhang, Jose Thaiparambil, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 8, pp. 884-893
Open Access | Times Cited: 8
Yitian Xu, Licheng Zhang, Jose Thaiparambil, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 8, pp. 884-893
Open Access | Times Cited: 8
The tumor microenvironment
Manzoor Ahmad Mir, Shariqa Aisha, Shazia Sofi, et al.
Elsevier eBooks (2022), pp. 31-58
Closed Access | Times Cited: 8
Manzoor Ahmad Mir, Shariqa Aisha, Shazia Sofi, et al.
Elsevier eBooks (2022), pp. 31-58
Closed Access | Times Cited: 8
Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma
Nicoletta Nastasi, Amada Pasha, Gennaro Bruno, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4744-4744
Open Access | Times Cited: 4
Nicoletta Nastasi, Amada Pasha, Gennaro Bruno, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4744-4744
Open Access | Times Cited: 4
Tea leaf-derived nanovesicles for ferric-supply-amplified ICD and macrophage reprogramming to boost immunotherapy against head and neck squamous carcinoma
Hanzhe Liu, Zhi Liu, Weilian Liang, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158469-158469
Closed Access | Times Cited: 1
Hanzhe Liu, Zhi Liu, Weilian Liang, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158469-158469
Closed Access | Times Cited: 1
The Roles of Myeloid Cells in Aging-related Liver Diseases
Jinghao Yao, Yang Li, Hua Wang
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1564-1578
Open Access | Times Cited: 4
Jinghao Yao, Yang Li, Hua Wang
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1564-1578
Open Access | Times Cited: 4
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state
Sandra Van Lint, Alexander Van Parys, Bram Van Den Eeckhout, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Sandra Van Lint, Alexander Van Parys, Bram Van Den Eeckhout, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4